点击蓝字关注我们急性脑水肿通常继发于脑卒中及创伤性脑损伤，其中促炎反应被认为是脑损伤后脑水肿进展及神经功能恶化的关键因素之一。然而，在创伤性脑损伤后采用糖皮质激素进行全身性抗炎治疗，并未能有效减轻脑水肿，反而导致死亡率上升，提示全身性抗炎治疗可能存在局限。大脑常驻免疫细胞小胶质细胞在损伤后被激活，其 ...

MOORHEAD, Minn. (KVLY/Gray News) - A Minnesota boy who suffered swelling and damage to his brain after spiking a fever of nearly 106 degrees has died. According to his mother, Zaydan came down with ...

An alternate dosing plan for the anti-amyloid drug donanemab (Kisunla) reduced the risk of brain edema and effusion but still maintained sufficient amyloid reduction in early Alzheimer's disease, the ...

In 2006, Kevin Sheth was a 26-year-old neurology resident in Boston, at both Massachusetts General Hospital and Brigham and Women’s Hospital. In that role, he did rotations within their neurology ...

Eli Lilly & Co. said that a small change in dosing its Alzheimer’s drug Kisunla cut patients’ rate of brain-swelling side effects in preliminary results from a study. A more gradual increase in the ...

Prothena Corporation plc (NASDAQ:PRTA) shared results on Wednesday from the Phase 1 ASCENT clinical program in participants with early symptomatic Alzheimer’s disease (AD). As previously communicated, ...